Athanasios I Kotsolis

Summary

Publications

  1. ncbi Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser
    Athanasios I Kotsolis
    Department of Ophthalmology, Medical School of Athens University, 11 Zefiron St, 15342, Athens, Greece
    Graefes Arch Clin Exp Ophthalmol 248:1553-7. 2010
  2. ncbi Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study
    Ioannis D Ladas
    First Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 30:1185-9. 2010
  3. ncbi Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration
    Ioannis D Ladas
    1st Department of Ophthalmology, Medical School of Athens University, Greece
    Retina 27:891-6. 2007
  4. ncbi Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections
    Ioannis D Ladas
    1st Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 29:313-8. 2009
  5. ncbi Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear
    Alexandros A Rouvas
    Second Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 31:1083-8. 2011
  6. ncbi Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
    Ioannis D Ladas
    Department of Ophthalmology, G Gennimatas Hospital of Athens, University of Athens, Athens, Greece
    Clin Ophthalmol 3:129-31. 2009
  7. ncbi Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
    Ilias Georgalas
    Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Clin Ophthalmol 3:13-6. 2009
  8. ncbi Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment
    Ioannis D Ladas
    Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Ophthalmologica 221:313-9. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser
    Athanasios I Kotsolis
    Department of Ophthalmology, Medical School of Athens University, 11 Zefiron St, 15342, Athens, Greece
    Graefes Arch Clin Exp Ophthalmol 248:1553-7. 2010
    ..To evaluate the efficacy of intravitreal injections of ranibizumab in patients with diabetic clinically significant macular edema (CSME), when further focal or grid laser was considered to be unsafe...
  2. ncbi Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study
    Ioannis D Ladas
    First Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 30:1185-9. 2010
    ..The purpose of this study was to evaluate the efficacy of intravitreal ranibizumab in eyes with macular choroidal neovascularization secondary to angioid streaks...
  3. ncbi Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration
    Ioannis D Ladas
    1st Department of Ophthalmology, Medical School of Athens University, Greece
    Retina 27:891-6. 2007
    ....
  4. ncbi Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections
    Ioannis D Ladas
    1st Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 29:313-8. 2009
    ..To compare the safety of repeat intravitreal injections of bevacizumab versus ranibizumab performed on a large series of patients during the past 2 years period of time...
  5. ncbi Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear
    Alexandros A Rouvas
    Second Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Retina 31:1083-8. 2011
    ..To evaluate the efficacy of intravitreal ranibizumab in eyes with exudative age-related macular degeneration associated with retinal pigment epithelial tear...
  6. ncbi Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
    Ioannis D Ladas
    Department of Ophthalmology, G Gennimatas Hospital of Athens, University of Athens, Athens, Greece
    Clin Ophthalmol 3:129-31. 2009
    ..The purpose of this observational case report is to describe a case of skin rash after intravitreal use of bevacizumab...
  7. ncbi Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
    Ilias Georgalas
    Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Clin Ophthalmol 3:13-6. 2009
    ....
  8. ncbi Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment
    Ioannis D Ladas
    Department of Ophthalmology, Medical School of Athens University, Athens, Greece
    Ophthalmologica 221:313-9. 2007
    ..To evaluate the efficacy of photodynamic therapy (PDT) in the treatment of subfoveal occult choroidal neovascularization (CNV) associated with serous pigment epithelium detachment (PED) in eyes with age-related macular degeneration...